- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02608554
Taichi for Overweight/Obese Adolescent and Young Women With Polycystic Ovary Syndrome (PCOS)
December 23, 2019 updated by: Yan Li, Heilongjiang University of Chinese Medicine
Taichi for Treating Overweight/Obese Adolescent and Young Women With Polycystic Ovary Syndrome (PCOS)
The present study is a randomized pilot study, overweight/obese adolescent and young PCOS subjects will be assigned into two groups: Taichi arm and control arm.
Hormonal profile and metabolic profile will be determined.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Heilongjiang
-
Harbin, Heilongjiang, China, 150040
- First Affiliated Hospital, Heilongjiang University of Chinese Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 35 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Women aged between 19 and 35 years;
- Diagnosis of PCOS according to the modified Rotterdam criteria;
- 2 years after menarche;
- Body mass index (BMI) equal to or greater than 23 kg/m*m.
Exclusion Criteria:
- Administration of other medications known to affect reproductive function or metabolism within the past three months, including oral contraceptives, Gonadotropin-releasing hormone (GnRH) agonists and antagonists, anti androgens, gonadotropins, anti-obesity drugs, Chinese herbal medicines, anti diabetic drugs such as metformin and thiazolidinediones, somatostatin, diazoxide, and calcium channel blockers.
- Patients with other endocrine disorder including 21-hydroxylase deficiency, hyperprolactinemia, uncorrected thyroid disease, suspected Cushing's syndrome.
- Patients with known severe organ dysfunction or mental illness.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Taichi
The 24 forms of simplified TCC recommended as the popular health sport by the General Administration of Sport of China were applied.
|
The program of Taichi training consisted of 60 minutes exercise sessions, 3 days per week for 12 weeks, based on their original level of physical activity.
Each session comprised 40 minutes of Taichi training plus a 10-minute warm-up and cool-down.
The Taichi training was instructed by the same experienced Taichi instructors who were qualified in the teaching of Taichi.
The 24 forms of simplified Taichi recommended as the popular health sport by the General Administration of Sport of China were applied.
|
ACTIVE_COMPARATOR: Self-monitored exercise
Exercise was self-monitored and consisted of brisk walking, cycling, jogging, or any other aerobic exercise.
|
Exercise was self-monitored and consisted of brisk walking, cycling, jogging, or any other aerobic exercise for 60 mins.
3 days per week for 12 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Body mass index (BMI)
Time Frame: 3 months
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fasting plasma glucose (Glu)
Time Frame: 3 months
|
3 months
|
|
Fasting insulin (Ins)
Time Frame: 3 months
|
3 months
|
|
HOMA-IR
Time Frame: 3 months
|
HOMA-IR = fasting insulin concentrations (mIU/L) ×fasting plasma glucose concentrations (mmol/L)/22.5
|
3 months
|
Testosterone (T)
Time Frame: 3 months
|
3 months
|
|
Luteinizing hormone (LH)
Time Frame: 3 months
|
3 months
|
|
Follicle stimulating hormone (FSH)
Time Frame: 3 months
|
3 months
|
|
Waist/hip ratio
Time Frame: 3 months
|
3 months
|
|
Ferriman-Gallwey score
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Li Y, Peng C, Zhang M, Xie L, Gao J, Wang Y, Gao Y, Hou L. Tai Chi for Overweight/Obese Adolescents and Young Women with Polycystic Ovary Syndrome: A Randomized Controlled Pilot Trial. Evid Based Complement Alternat Med. 2022 Jun 17;2022:4291477. doi: 10.1155/2022/4291477. eCollection 2022.
- Li Y, Peng C, Cao G, Li W, Hou L. Tai chi for overweight/obese adolescent and young women with polycystic ovary syndrome: study protocol for a randomized controlled trial. Trials. 2018 Sep 20;19(1):512. doi: 10.1186/s13063-018-2893-z.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
October 1, 2016
Primary Completion (ANTICIPATED)
December 31, 2019
Study Completion (ANTICIPATED)
March 31, 2020
Study Registration Dates
First Submitted
November 17, 2015
First Submitted That Met QC Criteria
November 17, 2015
First Posted (ESTIMATE)
November 18, 2015
Study Record Updates
Last Update Posted (ACTUAL)
December 26, 2019
Last Update Submitted That Met QC Criteria
December 23, 2019
Last Verified
December 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Taichi for PCOS
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Polycystic Ovary Syndrome
-
Cairo UniversityCompleted
-
Alexandria UniversityRecruitingPolycystic Ovary Syndrome (PCOS)Egypt
-
Saudi German Hospital - MadinahCompletedPolycystic Ovary Syndrome (PCOS)Saudi Arabia
-
University of CopenhagenCompletedPolycystic Ovary Syndrome (PCOS)Denmark
-
Odense University HospitalCompleted
-
Poznan University of Medical SciencesUniversity of California, DavisUnknownPolycystic Ovary Syndrome (PCOS)Poland
-
Assaf-Harofeh Medical CenterUnknownInfertility | Polycystic OvariesIsrael
-
Riphah International UniversityCompleted
-
Dexa Medica GroupCompletedPolycystic Ovary Syndrome (PCOS)Indonesia
-
Virginia Commonwealth UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...TerminatedPolycystic Ovary Syndrome (PCOS)United States
Clinical Trials on Taichi
-
Chengdu PLA General HospitalUnknown
-
Beijing Sport UniversityCompletedCardiovascular Diseases | Hypertension | Sleep Disorder | Cognitive Impairment | Metabolic DiseaseChina
-
Universiti Putra MalaysiaRecruitingPhysical Inactivity | Mental Health IssueChina
-
Universidade do PortoCompleted
-
Sheba Medical CenterTel Aviv UniversityWithdrawnOvarian Cancer | Primary Peritoneal Cancer | Other Gynecological CancersIsrael
-
Northeast Normal UniversityCompleted
-
Hugo W. Moser Research Institute at Kennedy Krieger...Suspended
-
Hugo W. Moser Research Institute at Kennedy Krieger...Active, not recruiting